Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Bernstein Starts Incyte with Growth ConcernsPayPal shareholders approve new equity planBuilding Collapse in Morocco: 14 DeadBernstein Initiates BioNTech Coverage with ConcernsGodfather 4: Connie StoryBernstein Starts Revolution Med at Market PerformChina football scandal: 17 banned for lifeBernstein Initiates Neurocrine with Outperform RatingHPE SWOT: Stock faces growth concerns amid AI pivotFrancis Hondal Buys $45,850 in Equitable Holdings StockBernstein Starts Incyte with Growth ConcernsPayPal shareholders approve new equity planBuilding Collapse in Morocco: 14 DeadBernstein Initiates BioNTech Coverage with ConcernsGodfather 4: Connie StoryBernstein Starts Revolution Med at Market PerformChina football scandal: 17 banned for lifeBernstein Initiates Neurocrine with Outperform RatingHPE SWOT: Stock faces growth concerns amid AI pivotFrancis Hondal Buys $45,850 in Equitable Holdings Stock
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#incyte

Latest news and interesting information about incyte.

Bernstein Starts Incyte with Growth Concerns
Today / 21:33
|
306

Bernstein Starts Incyte with Growth Concerns

Bernstein starts Incyte coverage with Market Perform rating and $99 target, highlighting Jakafi patent loss and growth concerns.

ANALYST RATINGS →
0
Biotech at Inflection Point: JPMorgan Covers 14 Firms | Bond.az
Yesterday / 19:01
|
686

Biotech at Inflection Point: JPMorgan Covers 14 Firms | Bond.az

JPMorgan covers 14 biotech firms at inflection point, with ratings and price targets. See which companies are poised for growth and the catalysts ahead.

STOCK MARKETS →
0
...